Angelo Armandi

58PUBLICATIONS
162CO-AUTHORS
Metabolic medicineEnvironmental epidemiologyMedical biochemistry - lipidsMedical biotechnology diagnostics (incl. biosensors)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Jul 17, 2026
Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0.

|Jul 15, 2026
Real-World Safety and Herpes Zoster Outcomes After Recombinant Zoster Vaccination in Inflammatory Bowel Disease.

|Mar 30, 2026
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes.

Yuping Chen, Bingtian Dong, Xinrui Jin

|Jul 30, 2025
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort.

Vlad Ratziu, Rambabu Surabattula, Elisabetta Bugianesi

|Jun 20, 2025
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.

Jimmy Che-To Lai, Boyu Yang, Hye Won Lee

|Jun 11, 2025
Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease and Associated Comorbidities on Cognitive and Health-Related Quality-of-Life Outcomes in a Mixed Metabolic Dysfunction-Associated Steatotic Liver Disease-Type 2 Diabetes Mellitus Cohort.

Nuria Perez-Diaz-Del-Campo, Gabriele Castelnuovo, Arianna Ferro

Pageof 10

Frequent Collaborators

33 joint publications

Gian Paolo Caviglia

28 joint publications

Chiara Rosso

27 joint publications

Davide Giuseppe Ribaldone

23 joint publications

Elisabetta Bugianesi